IPC
DPLO

Invesco Private Capital’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Invesco Private Capital’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,465
Closed -$47K – 6
2018
Q4 		$47K Sell
3,465
-3,500
-50% -$59K 0.02% 6
2018
Q3 		$135K Hold
6,965
– – 0.05% 7
2018
Q2 		$178K Buy
+6,965
New +$162K 0.06% 7

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Private Capital's DPLO Position: Q1 2019 in Review

Invesco Private Capital sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 3,465 shares — an estimated $47K sold.

Invesco Private Capital first reported a position in DPLO in Q2 2018 and held it in 3 quarters. The position peaked at $178K in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Invesco Private Capital reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • Invesco Private Capital sold 3,465 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $47K.
  • Invesco Private Capital first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2018 and held it in 3 quarters.
  • Invesco Private Capital's DIPLOMAT PHARMACY, INC. position peaked at $178K in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Invesco Private Capital's 13F filing for Q1 2019, filed 15 May 2019.